- Di sistema
- In an era of significant therapeutic innovation and the redefinition of new therapeutic paradigms for many hematological diseases, this event will provide a unique opportunity to compare the management of new drugs (small molecules, antibody-drug conjugates, bispecific antibodies, and cell therapies) between the italian and brazilian contexts, generating ideas for potential development or new research projects aimed at improving access to and management of treatments in both countries.